Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Histone acetylation in chromatin structure and transcription
1997 • 2,834 citations
Intracellular ATP levels determine cell death fate by apoptosis or necrosis.
1997 • 1,218 citations
p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
1995 • 1,193 citations
Histone deacetylase inhibitor selectively induces p21 WAF1 expression and gene-associated histone acetylation
2000 • 1,091 citations
Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases
1999 • 957 citations
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
1998 • 899 citations
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
1999 • 686 citations
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
1999 • 587 citations
A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture
1996 • 534 citations
p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
1998 • 530 citations
Effects of p21Waf1/Cip1/Sdi1on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases
2000 • 426 citations
Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects
1999 • 394 citations
Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway.
1997 • 376 citations
Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53
1999 • 282 citations
Histone Deacetylase Inhibitors Trigger a G2 Checkpoint in Normal Cells That Is Defective in Tumor Cells
2000 • 251 citations
Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase
1999 • 235 citations
Failure of Poly(ADP-Ribose) Polymerase Cleavage by Caspases Leads to Induction of Necrosis and Enhanced Apoptosis
1999 • 228 citations
Cleavage of CDK Inhibitor p21Cip1/Waf1 by Caspases Is an Early Event during DNA Damage-induced Apoptosis
1998 • 215 citations
Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.
1999 • 182 citations
Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors
1997 • 160 citations
Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21
1999 • 157 citations
Histone deacetylase inhibitors as potential anti-skin cancer agents.
1999 • 140 citations
Mitochondrial Regulation of Cell Death: Mitochondria Are Essential for Procaspase 3-p21 Complex Formation To Resist Fas-Mediated Cell Death
1999 • 133 citations
Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts
1999 • 132 citations
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
1999 • 114 citations
p21WAF1/CIP1 Inhibits Initiator Caspase Cleavage by TRAIL Death Receptor DR4
2000 • 97 citations
Chapter 3 Cell Cycle Phase-Specific Analysis of Cell Viability Using Hoechst 33342 and Propidium Iodide after Ethanol Preservation
1990 • 56 citations
Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells
1997 • 39 citations